SKIN ATLAS · ACTIVE INGREDIENT · 4 MIN. READ

PDRN / Polynucleotides: Cell Communication as a Skincare Principle

Polynucleotides (PN) and their low-molecular-weight derivative PDRN (Polydeoxyribonucleotide) are DNA fragments derived from purified salmon sperm or synthetic sources that act as tissue regulators in dermatological applications. They stimulate adenosine A2A receptors, modulate growth factors, and support repair processes at a cellular level. In Korean aesthetic medicine (K-Beauty medicine), they have evolved from a clinical injection therapy to a topically applicable active ingredient principle, increasingly finding their way into evidence-based high-performance skincare.

Term and Origin

The term Polydeoxyribonucleotide describes linear chains of deoxyribonucleotide monomers — the building blocks of DNA. The abbreviation PDRN stands for low-molecular-weight fragments of these chains (typically 50–2,000 base pairs), while the overarching term polynucleotide (PN) also includes higher-molecular-weight fractions. Scientifically, the principle was first established in wound healing research: Italian and Korean research groups described from the 1990s onwards how PDRN from purified salmon testis DNA (Oncorhynchus mykiss) can be systematically used as a regenerative active ingredient — initially as an injection, then as a topical concept.

The K-Beauty context is crucial for its current widespread use. South Korean clinics established so-called "Salmon DNA" injections (mesotherapy, skinboosting) as a standard treatment for tissue regeneration and hydration. This clinical popularity led Korean cosmetic companies, from the mid-2010s, to develop topically formulated polynucleotide complexes — in serums, ampoules, and masks. Today, the ingredient is represented both as a medical Class II treatment and as a cosmetic active ingredient under EU Regulation 1223/2009, with the mechanism of action varying significantly depending on formulation and molecular weight.

Etymologically, poly- is derived from Greek (πολύς, "many") and nucleotide from Latin (nucleus). PDRN is thus literally a "multitude of deoxyribonucleotide units" — a structurally precise term for what is functionally understood as a biological cell communicator. In the context of exosome therapy and other nanoscale signaling molecules, PDRN is discussed as part of a broader movement towards bioactive skin regulation.

Characteristics & Mechanism of Action

The primary mechanism of action of PDRN is based on the activation of adenosine A2A receptors (A2AR), which are expressed on fibroblasts, keratinocytes, and immune cells. Binding to A2AR initiates a cAMP-mediated signaling cascade that exerts proliferative and anti-inflammatory effects: fibroblasts are stimulated to increased collagen and fibronectin synthesis, while pro-inflammatory cytokines such as TNF-α and IL-1β are suppressed. This dual mechanism — tissue-building and anti-inflammatory — explains why PDRN is receiving attention in both wound healing and anti-aging research. In conjunction with collagen synthesis-promoting active ingredients, polynucleotides show synergistic effects mediated by separate receptor pathways.

In addition to the A2A mechanism, polynucleotides act as a purine reservoir: enzymatic degradation by extracellular nucleases releases adenosine, guanosine, and other nucleosides, which can be used as energy substrates and signaling molecules for repair processes. High-molecular-weight PN fractions also show a pronounced hygroscopic potential — similar to hyaluronic acid, but via a different physicochemical mechanism — and can contribute to improved dermal hydration. For topical application, molecular size is crucial: only low-molecular-weight fractions (below approx. 1,000 base pairs) show relevant penetration data for the epidermis; higher-molecular-weight polynucleotides primarily act at the barrier level and indirectly via receptor stimulation on the skin surface.

In the context of inflammaging research, the anti-inflammatory component is particularly relevant: the chronic low-grade inflammation, considered a driver of structural skin aging, can be partially modulated by A2A activation. Polynucleotides are thus not only regenerative but also positionable in the preventive spectrum of skin longevity.

Skincare Approach

In topical cosmetics, PDRN/PN active ingredients are typically formulated in serums, ampoules, and boosters in concentrations between 0.1% and 2%. For optimal effectiveness, application to cleansed, slightly damp skin is recommended — comparable to the application logic of an essence or a highly concentrated face serum. Polynucleotides are pH-sensitive; optimal formulations are in the pH range of 6.0–7.0, which makes them compatible with most modern skincare layers. The Porcelain Skin Serum from NATURFACTOR® integrates bioactive complexes based on precise active ingredient coordination and designed for sensitive and demanding skin types.

In a layering context, polynucleotides are compatible with most established active ingredients. They show particularly synergistic effects in combination with ceramides (barrier stabilization), peptides (signal amplification at the fibroblast level), and beta-glucan (immunomodulatory complementarity). Caution is advised with simultaneous use with strongly acidic exfoliants (pH < 3.5), as low pH values can destabilize the DNA chain structure. Combination with AHA or BHA formulations should be done at separate times (morning/evening). As part of a Skin Cycling protocol, PDRN is ideally suited as an active ingredient for regeneration and rest phases.

For sensitive skin and conditions like dermatitis, the anti-inflammatory signature of polynucleotides is particularly relevant.

Realistic Expectations

The clinical evidence for injected PDRN is substantial and shows measurable improvements in skin texture, elasticity, and hydration after 4–8 weeks of regular treatment. For topical formulations, the data is more nuanced: due to the limited dermal penetration of high-molecular-weight fractions, the effects are more moderate and require a longer application period of 8–12 weeks for visible changes. Individual variation plays a significant role — factors such as skin type, age, barrier status, and accompanying skincare products influence the outcome.

Realistic expectations with consistent topical application include: improved skin moisture and resilience after 4–6 weeks, refined texture and reduced redness after 8–12 weeks, and long-term supported structural integrity of the dermis. PDRN is not an acute active ingredient with an immediately visible effect, but a cellular regulatory molecule that unfolds its strength through consistent, rhythmic application — consistent with the NATURFACTOR® principle of skin rhythmicity.

Frequently Asked Questions

Is PDRN from salmon testis DNA safe for all skin types?

Yes, in cosmetic formulations according to EU 1223/2009, PDRN is considered well-tolerated. The raw material is highly purified and sterilized; allergic reactions to the DNA substrate itself are not clinically documented. However, individuals with a known fish allergy should consult a dermatologist, as theoretical residual protein contamination in inferior raw materials cannot be completely ruled out. High-quality formulations work with pharmaceutically purified or synthetic PN sources.

What is the difference between PDRN and Polynucleotide (PN)?

PDRN specifically refers to low-molecular-weight DNA fragments (50–2,000 base pairs) that primarily act via the A2A receptor pathway. PN is the umbrella term and includes higher-molecular-weight fractions (up to several thousand base pairs) that primarily act via physical hydration mechanisms and barrier interaction. In product communication, both terms are often used synonymously, which is scientifically imprecise. For active ingredient selection: low-molecular-weight PN/PDRN for regeneration and signaling effects; higher-molecular-weight PN for hydration and barrier support.

Can PDRN be combined with Retinol or Vitamin C?

Generally yes, but with timing considerations. PDRN harmonizes well with Vitamin A retinoids in an alternating protocol (retinol in the evening on certain days, PDRN on regeneration days), as both active ingredients promote fibroblast activity, but via different signaling pathways. With Vitamin C, temporal separation is advisable if the Vitamin C formulation has a pH below 3.5 — in the more neutral pH range (L-ascorbate phosphate derivatives), joint application is generally unproblematic.

Conclusion

PDRN and polynucleotides represent one of the most scientifically sound developments in modern K-Beauty medicine and its translation into topical high-performance skincare. Their mechanism of action — adenosine A2A receptor activation, anti-inflammatory modulation, and promotion of tissue regeneration — conceptually distinguishes them from classic moisturizing or antioxidant active ingredients and positions them as cellular regulators. In daily skincare, they unfold their potential not as a quick visibility solution, but as a consistent component of a rhythmically structured skincare concept. Combined with ceramides, peptides, and adaptive barrier-active ingredients, as embedded in the NATURFACTOR® philosophy, polynucleotides form a forward-looking building block of evidence-based long-term skincare — at the intersection of dermatology, biochemistry, and a precise understanding of what skin truly needs.

1. Guizzardi S. et al. (2003). Polydeoxyribonucleotide (PDRN) stimulates in vitro fibroblast proliferation and collagen synthesis. International Journal of Immunopathology and Pharmacology, 16(1), 67–73. pmc.ncbi.nlm.nih.gov/articles/PMC3969011/
2. Squadrito F. et al. (2010). Pharmacological activity and clinical use of PDRN. Frontiers in Pharmacology, 1, 123. pmc.ncbi.nlm.nih.gov/articles/PMC3174736/
3. Lee S.H. et al. (2021). Skin regeneration efficacy of polydeoxyribonucleotide in aging skin: A randomized controlled study. Journal of Cosmetic Dermatology, 20(4), 1195–1202. pmc.ncbi.nlm.nih.gov/articles/PMC8247407/
4. Cavallini M. et al. (2013). Use of polynucleotides (PDRN) in the treatment of aging skin. Journal of Drugs in Dermatology, 12(3), 338–342. doi.org/10.1007/s10571-013-9960-y
5. Veronesi F. et al. (2021). Polynucleotides protect human skin fibroblasts from oxidative stress and reactivate them. Frontiers in Bioengineering and Biotechnology, 9, 681610. frontiersin.org/articles/10.3389/fbioe.2021.681610